Talk
Oral Communications
Mon, Nov 16, 2026 · 5:30–6:15 PM EST Ballroom - 4th floor, Boston Marriott Copley Place
About this session
Oral communications: OC5 Agentic Artificial Intelligence in Alzheimer's Disease Clinical Trials: From Data-Driven Discovery to Adaptive Design Optimization and Statistical Validation; LB01 Spectris Treatment in Mild-to-Moderate Alzheimer's Disease: Topline Results and Secondary Analyses From the HOPE Pivotal Study; OC6 Long-Term Outcomes with Lecanemab in Early Alzheimer's Disease: Initial Findings Through 60-Months of Clarity AD Open-Label Extension.
Speakers
-
Washington University in St. Louis
Chair
-
Montpellier University
Chair